DENTSPLY SIRONA (NASDAQ:XRAY) issued its earnings results on Thursday. The medical instruments supplier reported $0.38 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.46 by ($0.08), RTT News reports. DENTSPLY SIRONA had a positive return on equity of 9.12% and a negative net margin of 39.62%. The company had revenue of $928.40 million during the quarter, compared to analyst estimates of $951.58 million. During the same period last year, the business earned $0.70 earnings per share. The firm’s revenue was down 8.0% compared to the same quarter last year. DENTSPLY SIRONA updated its FY 2018 guidance to $2.00 EPS and its FY18 guidance to $2.00-2.15 EPS.
Shares of NASDAQ:XRAY traded up $0.29 during midday trading on Thursday, reaching $36.80. 3,963,454 shares of the company’s stock were exchanged, compared to its average volume of 2,693,468. The company has a current ratio of 1.69, a quick ratio of 1.10 and a debt-to-equity ratio of 0.31. The company has a market capitalization of $7.90 billion, a price-to-earnings ratio of 13.83, a PEG ratio of 2.06 and a beta of 1.15. DENTSPLY SIRONA has a fifty-two week low of $33.93 and a fifty-two week high of $68.98.
Several large investors have recently modified their holdings of XRAY. Orbimed Advisors LLC increased its position in shares of DENTSPLY SIRONA by 963.8% during the 2nd quarter. Orbimed Advisors LLC now owns 2,393,500 shares of the medical instruments supplier’s stock worth $104,763,000 after purchasing an additional 2,168,500 shares during the last quarter. Veritas Asset Management LLP grew its position in DENTSPLY SIRONA by 18.2% in the 3rd quarter. Veritas Asset Management LLP now owns 11,928,003 shares of the medical instruments supplier’s stock valued at $450,163,000 after acquiring an additional 1,835,402 shares in the last quarter. Nuance Investments LLC grew its position in DENTSPLY SIRONA by 134.6% in the 2nd quarter. Nuance Investments LLC now owns 2,174,311 shares of the medical instruments supplier’s stock valued at $95,170,000 after acquiring an additional 1,247,670 shares in the last quarter. Manitou Investment Management Ltd. acquired a new position in DENTSPLY SIRONA in the 3rd quarter valued at about $28,582,000. Finally, Thompson Siegel & Walmsley LLC grew its position in DENTSPLY SIRONA by 43.1% in the 2nd quarter. Thompson Siegel & Walmsley LLC now owns 2,213,839 shares of the medical instruments supplier’s stock valued at $96,899,000 after acquiring an additional 667,148 shares in the last quarter. 97.90% of the stock is owned by hedge funds and other institutional investors.
DENTSPLY SIRONA Company Profile
DENTSPLY SIRONA Inc designs, develops, manufactures, and markets various dental and oral health products, and other consumable healthcare products primarily for the professional dental market worldwide. The company operates in two segments, Technologies & Equipment; and Consumables. Its dental supplies include endodontic instruments and materials, dental anesthetics, prophylaxis pastes, dental sealants, impression materials, restorative materials, tooth whiteners, and topical fluoride products; and small equipment products comprise dental hand pieces, intraoral curing light systems, dental diagnostic systems, and ultrasonic scalers and polishers.
Recommended Story: The Role of a Fiduciary and Individual Investors
Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.